Roberto Chiarle
Boston Children's Hospital(US)University of Turin(IT)European Institute of Oncology(IT)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Lung Cancer Treatments and Mutations, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Immune Cell Function and Interaction
Most-Cited Works
- → The anaplastic lymphoma kinase in the pathogenesis of cancer(2007)870 cited
- → Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing(2013)484 cited
- → Genome-wide Translocation Sequencing Reveals Mechanisms of Chromosome Breaks and Rearrangements in B Cells(2011)465 cited
- → Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target(2005)435 cited
- → Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death(2002)390 cited
- → The BRAF Pseudogene Functions as a Competitive Endogenous RNA and Induces Lymphoma In Vivo(2015)366 cited